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Abstract
Rationale Acute tryptophan depletion (ATD) transiently 
lowers central serotonin levels and can induce depressive 
mood states and cognitive defects. Previous studies have 
shown that ATD impairs object recognition in rats. 
Objectives As individual differences exist in central sero­
tonin neurotransmission, the impact of ATD may vary
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accordingly. In this experiment, we investigated the hypoth­
esis that male serotonin transporter knockout (SERT ), rats 
marked by a lower SERT function, are more vulnerable to 
the effects of ATD in an object recognition task than male 
wildtype (SERT+/+) and heterozygous (SERT+/-) rats. 
Materials and methods Twelve male SERT+/+, SERT+/-, 
and SERT- -  rats were treated with standard dose and low- 
dose ATD using a gelatine-based protein-carbohydrate 
mixture lacking tryptophan. In the control treatment, L- 
tryptophan was added to the mixture. Four hours after 
treatment, the rats were subjected to the object recognition 
task. In addition, the effects of ATD on plasma amino acid 
concentrations were measured, and concentrations of 5-HT 
and 5-HIAA were measured in the frontal cortex and 
hippocampus of these rats.
Results Plasma TRP levels and central 5-HT and 5-HIAA 
levels were decreased in all genotypes after ATD, but 
effects were stronger in SERT-/- rats. The standard dose of 
ATD impaired object recognition in all genotypes. SERT 
and SERT+ rats were more vulnerable to low dose of ATD 
in the object recognition task compared to SERT+ + rats. 
Conclusions These results indicate a greater sensitivity to 
ATD in SERT- -  and SERT+- rats, which may be related to 
stronger central depletion effects in these rats.
Keywords Acute tryptophan depletion. Knockout. 
Serotonin. Serotonin transporter. Object recognition. 
5-HIAA . Hippocampus . Frontal cortex
Introduction
Memory is a multifaceted cognitive function relating to the 
acquisition and storage of information for shorter or longer 
periods of time and the subsequent retrieval of this
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information. The role of the neurotransmitter serotonin 
(5-hydroxytryptamine, 5-HT) in learning and memory has 
been demonstrated in both humans and animals (Buhot 
1997; Buhot et al. 2000; Meneses 1999; Riedel et al. 1999; 
Schmitt et al. 2000). Studies using the method of acute 
tryptophan depletion (ATD), which results in lower periph­
eral and central levels of tryptophan and 5-HT (Biggio et al. 
1974; Fernstrom and Wurtman 1997; Gessa et al. 1974; 
Moja et al. 1989; Stancampiano et al. 1997), consistently 
report impaired memory in healthy volunteers (Park et al. 
1994; Riedel et al. 1999; Sambeth et al. 2007; Schmitt et al. 
2000) and rats (Jans et al. 2007a; Lieben et al. 2004b; 
Rutten et al. 2007). More specifically, ATD studies have 
shown impairments of long-term memory performance 
(Riedel et al. 2002) and reduced ability to actively recall, 
as well as recognize, words from a previously presented 
word list (Riedel et al. 1999). Whereas consolidation of 
new information into long-term memory appeared to be 
compromised by a reduction of central 5-HT activity; short­
term memory functions were intact. Several studies have 
subsequently confirmed that 5-HT is specifically involved 
in long-term memory functioning (for review, see Sambeth 
et al. 2007; Schmitt et al. 2006). Interestingly, ATD did not 
affect long-term memory retrieval or recognition when the 
depletion was induced after learning and consolidation of a 
word list (Schmitt et al. 2000). Thus, these results suggest 
that consolidation of new information into long-term 
memory requires normal 5-HT functioning.
The serotonin transporter (SERT) has an important role 
in the re-uptake of 5-HT from the synapse, returning it to 
the presynaptic neuron where it can be degraded or retained 
for future release. In fact, the SERT has an essential role in 
serotonergic neurotransmission as it determines the magni­
tude and duration of the 5-HT signal in the synaptic cleft. 
We recently developed a SERT knockout (SERT-/-) rat 
using N-ethyl-N-nitrosurea-driven mutagenesis (Smits et al. 
2004; Smits et al. 2006). This animal has a premature 
stopcodon (TGC>TGA) introduced at position 3924 in the 
third exon encoding the second extracellular loop of the 
SERT protein. Consistent with the absence of SERT in 
these rats, northern blot analysis revealed that the mutation 
resulted in nonsense-mediated decay of the mutant SERT 
transcript and showed reduced SERT mRNA transcript in 
the SERT heterozygous knockout (SERT+ -) rat (Homberg 
et al. 2007a). In addition, [3H]citalopram (SSRI) binding to 
brain slices of SERT- -  rats is completely absent, whereas 
in SERT+- rats, citalopram binding was reduced by 
approximately 40%. Moreover, extracellular 5-HT levels 
in the hippocampus of SERT-/- are nine-fold elevated 
(Homberg et al. 2007a; Olivier et al. 2008), whereas in 
SERT+ rats, extracellular 5-HT levels are similar to 
wildtype littermates (SERT+ ) (Olivier et al. unpublished 
data). However, intracellular 5-HT levels were reduced by
approximately 75-50% in SERT-/- rats and by 45-55% in 
SERT+- rats in several brain areas (Homberg et al. 2007a).
In humans, a polymorphism in the 5-HT transporter 
gene-linked promoter region (5-HTTLPR) results in indi­
vidual differences in SERT expression and function (Heils 
et al. 1996; Lesch et al. 1996). Several studies have shown 
that 5-HTTLPR genotype can influence behavioral 
responses to ATD (Marsh et al. 2006; Neumeister et al. 
2006; Roiser et al. 2006; Walderhaug et al. 2007). As 
wildtype (SERT+/+), heterozygous (SERT+/-), and knockout 
(SERT- - ) rats exhibit large differences in central 5-HT 
neurotransmission, the impact of ATD may vary accord­
ingly in these rats. In this study, these different types of rat 
were subjected to two different doses of ATD—a standard 
dose and a low dose—and tested for memory in the object 
recognition task. Animals with lower SERT function were 
hypothesized to be more vulnerable to the effects of ATD 
on object recognition memory as they rely more heavily on 
5-HT synthesis than animals in which the re-uptake 
mechanism is fully functional. The magnitude of the 
depletion was determined by measuring plasma amino acid 
concentrations of TRP and five other large neutral amino 
acids (LNAAs: valine, leucine, isoleucine, phenylalanine, 
tyrosine) that compete with TRP for transport across the 
blood-brain barrier. The ratio of TRP and these other 
LNAAs (TRP/ELNAA ratio) is thought to be a more 
sensitive index of brain tryptophan availability than plasma 
TRP (Fernstrom 1981; Wurtman et al. 1980) because this 
ratio determines the amount of tryptophan that can enter the 
brain. Moreover, 5-HT and 5-HIAA concentrations were 
measured in the frontal cortex and the hippocampus, the 
brain regions involved in cognition and memory (Dalley et 
al. 2004; Heidbreder and Groenewegen 2003; Squire and 
Zola-Morgan 1991; Wurtman et al. 1980).
Experimental procedures
Animals
The serotonin transporter knockout rat (Slc6a41Hubr) has been 
generated, bred, and reared in the Central Animal Laboratory 
of the Radboud University of Nijmegen. Experimental 
animals were derived from crossing SERT+ -  rats that were 
outcrossed for four or five generations. Twelve male SERT+ +, 
SERT+-, and SERT- -  littermates (age: 3 to 5 months old) 
were used in this experiment. After weaning at the age of 
21 days, ear cuts were taken for genotyping. Genotyping 
was performed at the Hubrecht Institute (Utrecht, The 
Netherlands), and the procedure has been described 
elsewhere (Homberg et al. 2007a). During the experiment, 
all animals were individually housed in standard Macrolon® 
type 3 cages (42x26x20 cm) in temperature-controlled
Ô  Springer
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rooms (21±1°C) with standard 12/12-h day/night cycle 
(lights on at 7.00 am .) and food (Sniff, long cut pellet, Bio 
Services, Uden, The Netherlands) and water available ad 
libitum.
Drugs and chemicals
The gelatin hydrolysate (Solugel P®) was obtained from PB 
Gelatins (Tessenderlo, Belgium). Glucodry 210 was 
obtained from Tate & Lyle (Koog aan de Zaan, The 
Netherlands). Kaliumchloride (KCl) and calciumchloride- 
dihydrate (CaCl2 2H2O) were purchased from Merck 
(Darmstadt, Germany). L-Tryptophan was obtained from 
Sigma (Zwijndrecht, The Netherlands).
Treatment
During a period of 2 weeks preceding the experiment, the 
rats were handled and habituated to oral injections with 
normal tap water (up to 10 ml/kg). The experiment 
consisted of blood sample collection (right after the 
handling period), object recognition task, and brain sample 
collection (1 week after object recognition task). On blood 
and brain sampling days, rats were treated with a protein­
carbohydrate mixture containing L-TRP (TRP+ group, 
0.30% TRP of the total protein) or lacking l-TRP (TRP-
100 g group). In all treatment conditions, rats received two 
oral injections of 10 ml/kg with a 90-min interval. Blood 
samples were taken at baseline (10 min before the first 
injection) and 4 h after the first injection. Brain samples 
were taken without treatment and 4 h after the first 
treatment. The composition of the nutritional mixture is 
shown in Table 1. In the object recognition task, rats were 
tested without treatment, with TRP+, with TRP- 100 g 
(standard-dose ATD), and with TRP- 40 g (low-dose 
ATD), respectively, with a 2-day interval. The TRP- 40 g 
condition is a mixture containing 40 g instead of the 
standard 100 g of Solugel P protein per 100 ml. Because 
TRP was absent and amino acids were given in a lower 
concentration, this resulted into milder tryptophan deple­
tion. On each testing day, behavioral testing was conducted
4 h after the first oral administration. Treatment always took 
place between 8.30 and 12.00 h, and the object recognition 
task was performed between 12.30 and 17.00 h. The rats 
were fasted from 14 h prior to treatment until the testing 
period was completed. This was done to minimize the 
availability of TRP from food. At the end of each testing 
day, the animals had ad libitum access to food.
Biochemistry
Plasma amino acid levels For the determination of plasma 
amino acid levels, blood samples were taken at baseline
Table 1 Composition of the treatment mixtures
Substance Standard Low
dose dose
Protein (Solugel P®) in 100 ml water 100 40
Aspartic acid 4.8
Glutamic acid 10.3
Hydroxyproline 11.4
Serine 3.4
Glycine 23.2
Histidine 0.8
Arginine 10.0
Threonine 2.0
Alanine 10.4
Proline 12.0
Tyrosine 0.4
Valine 2.2
Methionine 0.7
Isoleucine 1.0
Leucine 2.5
Hydroxylysine 0.9
Phenylalanine 1.1
Lysine 2.9
Carbohydrate (Glucodry 210) in 80 ml 50 50
water
KCl 0.094 0.094
CaCl2-2H2O 2.32 2.32
L-tryptophan (TRP- groups) 0 0
L-tryptophan (TRP+ group) 0.28 0.28
(T0; i.e., 10 min before the first oral administration) and 
repeated 4 h after the first administration (T4). Blood 
sampling was done via a tail-incision method (Fluttert et al. 
2000). Promptly after collection of blood in a sodium 
heparin tube (Microvette® CB 300, Sarstedt, Germany), the 
samples were kept on ice. After centrifugation of the blood 
samples (at 4°C for 15 min at 3,000xg), plasma samples were 
stored at -70°C. Plasma amino acid concentrations were 
determined with a fully automated high-performance liquid 
chromatography (HPLC). The concentrations of the total 
plasma amino acids are expressed as micromoles per liter.
Brain 5-HT and 5-HIAA levels Animals were decapitated, 
and tissue samples (frontal cortex and hippocampus) were 
dissected from the brain, weighed, and stored at -80°C 
until further use. The tissue samples were homogenized in 
250 |o.l of an ice-cold solution containing 5 (0.M clorgyline,
5 Mg/ml glutathione, and 0.6 (0.M No>-methylserotonin 
(internal standard) using a potter tube. To 100 |o.l homog- 
enate, 25 |o.l of 2 M HClO4 was added and mixed. Then, 
20 Ml of 2.5 M potassium acetate was added and again 
mixed. After 15 min in ice water, the homogenates were 
centrifuged for 15 min at 15,000xg (4°C). The supernatants 
were diluted ten times with water before HPLC analysis. 
The concentration of 5-HT and 5-HIAA in the tissue
^  Springer
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extracts were measured by HPLC with ECD. The HPLC 
system consisted of a pump model P100, an autosampler 
model AS300 (both from Thermo Separation Products, 
Waltham, MA, USA), an ERC-3113 degasser (Erma CR. 
Inc. Tokyo, Japan), an ESA Coulochem II detector with 
5011 analytical cell set at potential +450 mV (ESA Inc. 
Bedford MA, USA), a BD 41 chart recorder (Kipp & zn, 
The Netherlands), and a column (150 mmx4.6 mm i.d.) 
packed with Hypersil BDS C18, 5-^.m particle size (Alltech 
Associates, USA). The mobile phase solution consisted of 
50 mM citric acid, 50 mM phosphoric acid, 0.1 mM EDTA, 
45 Ml/l dibutylamine, and 77 mg/l 1-octanesulfonic acid 
sodium salt, 10% methanol; the pH of the buffer was 
adjusted to 3.4 with NaOH. Separation was performed at 
room temperature using a flow rate of 0.7 ml/min. The 
concentration of each compound was calculated by com­
parison with both the internal and the external standards. 
The limit of detection (signal/noise ratio 3:1) was 0.3 nM. 
Concentrations are expressed as nanomoles per gram. The 
5-HIAA/5-HT turnover was calculated, which can be used 
as an index of 5-HT system activity.
Behavior
Object recognition task The object recognition task was 
performed as described elsewhere (Ennaceur and Delacour 
1988; Prickaerts et al. 2002). The apparatus consisted of a 
square arena (100x100x40 cm), with an open top, dark 
walls, and a dark floor. Testing was carried out in dimmed 
white light. We used four different sets of objects that could 
not be displaced by the rat. Each object was available in 
triplicate. The different objects were (1) a bowl with handle 
made of green china (maximum diameter of 15 cm and a 
height of 9 cm); (2) a cubic box (12x12x7 cm) made of 
polyvinyl, with a pink topping; (3) a china trapezium 
cylinder (maximum diameter of 12 cm and minimum 
diameter of 10.5 cm) with a dish on top (diameter, 
12 cm); and (4) a brown tinned cylinder (diameter, 9.5 cm 
and height, 15 cm).
One day preceding testing, the animals were adapted to the 
procedure, i.e., they were allowed to explore the apparatus 
(without any objects) for 3 min. In the following days, the 
rats were tested twice. A testing session is comprised of two 
3-min trials, with a 1-h interval between trials. Two objects 
were placed in a symmetrical position about 10 cm away 
from the black wall. A rat was always placed in the 
apparatus facing one corner, which was the same for all 
rats. During the first trial, the apparatus contained two 
identical objects. After the first exploration period, the rat 
was put back in its home cage. One hour later, the rat was 
put back in the apparatus for the second trial but now with
dissimilar objects: a familiar one and a new one. The 
duration of exploring each object in both trials was 
recorded manually on a personal computer. Exploration 
was defined as directing the nose to the object at a distance 
of no more than 2 cm and/or touching the object with the 
nose. Sitting on the object was not considered as explor­
atory behavior. In order to avoid the presence of olfactory 
trails, the objects were thoroughly cleaned between trials 
with a 70% ethanol solution. Moreover, each object was 
available in triplicate so that none of the two objects from 
the first trial had to be used as the familiar object in the 
second trial. In addition, all combinations and locations of 
objects were used in a balanced manner to reduce potential 
biases due to preferences for particular locations or objects.
The basic measures in the object recognition task were 
the times spent by rats exploring an object during trial 1 
and trial 2. The discrimination index d2 [(exploration new 
object during trial 2 -exploration familiar object during trial 
2)/total exploration time during trial 2] was calculated for 
each treatment condition (see Rutten et al. 2007). The d2 is 
a relative index of discrimination between new and familiar 
objects because it corrects for total exploration time in trial 
2 (see §ik et al. 2003). Rats that explored less than 5 s in 
any of the trials or explored only one of the objects were 
removed from analysis to avoid possible erroneous con­
clusions (see §ik et al. 2003).
Statistical analysis
For all variables, treatment effects were analyzed using 
parametric statistics (ANOVA). Plasma amino acid concen­
trations were analyzed with repeated measures ANOVA, 
with factors genotype, treatment, and time. Brain 5-HT, 5- 
HIAA, and 5-HIAA/5-HT turnovers were analyzed with 
two-way ANOVA, with factors treatment and genotype. 
Where appropriate, post hoc testing with Bonferroni 
correction was used. In the object recognition task, effects 
of treatment and genotype on exploration times in each trial 
was analyzed using a two-way ANOVA. Where appropriate, 
post hoc testing with Bonferroni correction was used. We 
compared the d2 values of untreated testing and treatment 
conditions with d2 values of a virtual control group (see §ik 
et al. 2003). The virtual control group had a d2 of zero, 
meaning that there was no object recognition. The number of 
animals and SEM were similar to those of our treatment 
groups. Comparison with this virtual control group is used to 
evaluate more reliably whether discrimination performance 
differs from zero in a certain treatment condition. The d2 
values were compared with ANOVA, and a one-sided 
Dunnett post hoc test was used to test whether d2 in a 
treatment condition was higher than in the virtual control 
group, which would indicate that the rats are able to 
discriminate the objects.
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Results
Plasma amino acid concentrations
To determine the effects of the treatment conditions, plasma 
amino acid concentrations were measured, and the TRP/ 
ELNAA ratio was calculated for each measurement, 
treatment, and genotype (Fig. 1). Plasma TRP levels and 
the plasma TRP/ELNAA ratio decreased over the 4 h 
[Time: TRP: F(1, 29)=45.20, p <0.001; ratio: F(1, 29)= 
31.43, p <0.001]. Plasma TRP levels and the TRP/ELNAA 
ratio were lower in the TRP- 100 g group compared to the 
TRP+ group [Treatment: TRP: F(1, 29)=77.46, p <0.001; 
ratio: F(1, 29)=84.91, p <0.001]. There was no Time x 
Genotype x Treatment interaction effect and no Genotype x 
Treatment interaction effect on TRP or on the ratio (F’s< 
2.15, ns). A Time x Treatment interaction effect was found 
on TRP [F(1, 29)=206.17, p <0.001] and on the TRP/ 
ELNAA ratio [F(1, 29)=181.17, p <0.001]. Further analy­
sis showed that in the TRP+ condition, there was a 
significant increase of TRP and the TRP/ELNAA ratio 
over the 4 h [TRP: F(1, 13)=26.26, p <0.001; ratio: F(1, 
13)=23.01, p <0.001], whereas in the TRP- 100 g condi­
tion, these were significantly decreased [TRP: (1,14)= 
223.26, p <0.001; ratio: F(1, 14)=222.13, p <0.001]. There 
was no Time x Genotype effect and no effect of genotype 
on TRP levels and on the TRP/ELNAA ratio. Thus, TRP- 
100 g ATD resulted in strong depletion of plasma TRP and 
the TRP/ELNAA ratio, whereas TRP+ treatment caused an 
increase in TRP and the TRP/ELNAA ratio. These effects 
were similar in all genotypes.
Brain 5-HT and 5-HIAA concentrations
To determine the central effects of the treatment, concen­
trations of 5-HT and 5-HIAA were determined in the frontal
cortex and in the hippocampus, and for both structures, the 
turnover (5-HIAA/5-HT) was calculated (Table 2).
5-HT  In the frontal cortex, a treatment effect on 5-HT was 
found [F(2, 66)=41.46,p <0.001]. Post hoc testing revealed 
that 5-HT levels were lower in the TRP- 100 g condition 
than in the untreated condition and the TRP+ condition 
(Fig. 2a). Furthermore, 5-HT concentrations in the TRP+ 
condition were higher than in the untreated rats. Moreover, 
a genotype effect on 5-HT in the frontal cortex [F(2, 66)= 
73.76, p <0.001] was found. Post hoc analysis showed that 
5-HT levels in SERT-/- rats were lower than in SERT+- 
and SERT+ + rats. No Treatment x Genotype interaction 
effect on 5-HT was found in the frontal cortex. In the 
hippocampus, similar effects were found to the prefrontal 
cortex. In this structure also, a treatment effect on 5-HT [F 
(2, 66)= 17.85, p <0.001] was found, with lower 5-HT 
levels in the TRP- 100 g condition than in the untreated 
condition and in the TRP+ condition (Fig. 2a). Similar to 
the frontal cortex, 5-HT concentrations in the hippocampus 
were higher in the TRP+ condition than in the untreated 
rats. Also, a genotype effect on 5-HT was found in the 
hippocampus [F(2, 66)=67.25, p <0.001], with lower 5-HT 
levels in SERT / rats compared with SERT+/ and SERT+ + 
rats. No Treatment x Genotype interaction effects were 
found on 5-HT in the hippocampus.
In order to test our specific hypotheses, we also analyzed the 
effects of treatment on behavior in each experimental group 
separately. In the frontal cortex, 5-HT levels in the TRP- 100 g 
group were significantly lower than in the TRP+ group in all 
genotypes [Treatment: SERT+/+: F(2, 20)=9.80, p <0.001; 
SERT+- : F(2, 21)=12.75, p <0.001; SERT- - : F(2, 21)= 
27.88, p <0.001]. In SERT+/+ and SERT+- rats, 5-HT levels 
were higher in the TRP+ group than in the untreated rats, 
which was not the case in SERT- -  rats. In SERT- -  rats, 5-
Fig. 1 Effects of treatment with 
TRP+ or TRP- 100 g on plasma 
TRP/ELNAA ratio of all groups 
at baseline (T0) and 4 h after the 
first administration of the mix­
ture (T4). Percentage difference 
in TRP/ELNAA ratio between 
the baseline and the TRP+ and 
TRP- 100 g condition after 4 h 
is indicated in the graph
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Table 2 An overview of 5-HT, 5-HIAA, and 5-HIAA/5-HT turnover levels in frontal cortex and hippocampus
Brain area Treatment Genotype 5-HIAA (nmol/g) Sign. 5-HT (nmol/g) Sign. 5-HIAA/5-HT Sign.
Fr cortex Untreated SERT+/+ 1.19 a 2.74 a 0.46
Fr cortex Untreated SERT+/- 1.01 a 2.67 a 0.40
Fr cortex Untreated SERT-/- 0.63 1.39 0.46
Fr cortex TRP+ SERT+/+ 0.99 a 3.38 a 0.31
Fr cortex TRP+ SERT+/- 0.98 a 3.68 a, b 0.27
Fr cortex TRP+ SERT-/- 0.51 1.90 0.29
F cortex TRP- 100 g SERT+/+ 0.65 ccd 2.21 a, b, c 0.30 a, b
Fr cortex TRP- 100 g SERT+/- 0.63 a, b 2.16 a, b 0.30 a, b
Fr cortex TRP- 100 g SERT-/- 0.35 b 0.51 b, c 0.74 b, c
Hippocampus Untreated SERT+/+ 1.77 a 1.83 a 1.06
Hippocampus Untreated SERT+/- 1.52 a 1.82 a 0.86
Hippocampus Untreated SERT-/- 0.92 0.79 1.26
Hippocampus TRP+ SERT+/+ 1.49 a 2.11 a 0.73
Hippocampus TRP+ SERT+/- 1.33 a 2.48 a, b 0.58
Hippocampus TRP+ SERT-/- 0.51 1.90 0.29
Hippocampus TRP- 100 g SERT+/+ 0.84 a, b, c 1.56 a 0.56 a, b
Hippocampus TRP- 100 g SERT+/- 0.80 a, b, c 1.37 a, c 0.59 a
Hippocampus TRP- 100 g SERT-/- 0.35 B 0.51 b, c 0.74 b, c
a Significantly different from SERT - rats, b significantly different from untreated group with the same genotype, c significantly different from 
TRP+ treated group with the same genotype
HT was lower in the TRP- 100 g condition than in untreated 
rats, which was not the case in SERT+ + and SERT+- rats. In 
the hippocampus, there was a treatment effect on 5-HT in 
SERT+- [F(2, 21)=9.29, p <0.001] and in SERT-/- rats [F(2, 
21)=20.88, p <0.001] but not in SERT+/+ rats. In SERT+/- 
rats, 5-HT levels in the TRP+ condition were higher than in 
untreated and TRP- 100 g treated rats. In SERT / rats, 5-HT 
levels in the TRP- 100 g condition were lower than in the 
TRP+ condition and in untreated rats.
5-HIAA A treatment effect on 5-HIAA was found in the 
frontal cortex [F(2, 66)=23.98, p <0.001; see Fig. 2b]. Post 
hoc testing showed that 5-HIAA concentrations in the 
TRP- 100 g condition were lower than in the untreated rats 
and in the TRP+ condition. In the frontal cortex, a genotype 
effect was found on 5-HIAA in the frontal cortex [F(2, 66)= 
34.03, p <0.001]. Post hoc analysis showed that 5-HIAA
levels in SERT-/- were lower than in SERT+/- and SERT+/+ 
rats. No Treatment x Genotype interaction effects on 5- 
HIAA were found in the frontal cortex. Similar to the frontal 
cortex, a treatment effect on 5-HIAA was also found in the 
hippocampus [F(2, 66)=34.35, p <0.001]. As shown in 
Fig. 2b, 5-HIAA concentrations in the TRP- 100 g condition 
were lower than in the untreated rats and the TRP+ 
condition. In the hippocampus, 5-HIAA levels were higher 
in untreated rats than in TRP+ treated rats. Moreover, a 
genotype effect on 5-HIAA was found in the hippocampus 
[F(2, 66)=35.30, p <0.001], showing lower 5-HIAA levels 
in SERT- -  rats compared with SERT+- and SERT+ + rats.
No Treatment x Genotype interaction effects on 5-HIAA 
levels were found in the hippocampus.
In all genotypes, there was a treatment effect on 5-HIAA 
in the frontal cortex [SERT+/+: F(2, 20)=18.69, p <0.001; 
SERT+/-: F(2, 21)=4.29, p <0.05; SERT-/-: F(2, 21)= 
10.66, p <0.001]. Post hoc testing revealed that in SERT+/+ 
rats, 5-HIAA was lower in the TRP- 100 g group compared 
to the TRP+ group (p<0.01) and the untreated group (p< 
0.001). In SERT+- and SERT- -  rats, 5-HIAA levels were 
lower in TRP- 100 g compared to untreated rats (SERT+/ : 
p <0.05; SERT-/-: p <0.001). For the hippocampus also, 
there was a treatment effect in all genotypes in the 
hippocampus as well [SERT+/+: F(2, 20)=28.19, p <0.001; 
SERT+/-: F(2, 21)=7.16, p <0.001; SERT-/-: F(2, 21)= 
11.91, p <0.001]. Post hoc testing showed lower 5-HIAA 
levels in SERT+/+ and SERT+/- rats in the TRP- 100 g 
group compared with the TRP+ (SERT++: p <0.001; 
SERT+/ : p <0.05) and untreated group (SERT++: p <
0.001; SERT+ - : p <0.01). In SERT- -  rats, 5-HIAA was 
higher in the untreated rats compared with TRP+ (p<0.05) 
and TRP- 100 g (p<0.001) treated rats.
5-HIAA/5-HT As seen in Fig. 2c, there was a Treatment x 
Genotype interaction effect on the 5-HIAA/5-HT turnover 
in the frontal cortex [F(4, 62)=9.628, p <0.001] caused by 
the high 5-HIAA/5-HT turnover rate of SERT / rats. A 
treatment effect was found on the turnover in the frontal 
cortex [F(2, 62) =11.60, p <0.001]. Post hoc testing 
revealed that the turnover was lower in the TRP+ condition
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Fig. 2 Effect of treatment with 
TRP+ or TRP- 100 g on basal 
brain 5-HT (a), 5-HIAA (b), and 
5-HIAA/5-HT turnover (c) levels 
in the frontal cortex and hippo­
campus. Bars represent mean and 
standard error. Numbers above 
the bars represent percentage 
difference from the untreated 
condition
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than in the untreated rats and in the TRP- 100 g condition. 
Moreover, a genotype effect on 5-HIAA in the frontal 
cortex [F(2, 62)= 13.64, p <0.001] was found. The turnover 
was higher in SERT / rats than in SERT+/ and SERT+ + 
rats. Similarly to the frontal cortex, a Treatment x Genotype 
interaction effect on the 5-HIAA/5-HT turnover was also 
found in the hippocampus [F(4, 62)= 12.60, p <0.001]. This 
effect seems to be the result of the high 5-HIAA/5-HT 
turnover rate in SERT- -  rats. Moreover, a treatment effect 
on the turnover was found in the hippocampus [F(2, 62)= 
9.02, p <0.001], again, with a lower turnover in the TRP+ 
condition compared with the untreated rats and the TRP- 
100 g condition. Similar to the frontal cortex, a genotype 
effect on 5-HIAA/5-HT was found in the hippocampus 
[F(2, 62)=28.62, p <0.001], with a higher turnover in 
SERT- -  rats compared with SERT+- and SERT+ + rats.
In all genotypes, there was a treatment effect on 5-HIAA/ 
5-HT turnover in the frontal cortex [SERT+ +: F(2, 20)=4.64, 
p <0.05; SERT+- : F(2, 21)=3.78, p <0.05; SERT- - : F(2, 
21)= 16.37, p <0.001]. Post hoc testing showed that in 
SERT+/+ rats, the 5-HIAA/5-HT was lower in the TRP- 
100g group compared to the untreated group (p<0.05). In 
SERT+- rats, 5-HIAA/5-HT was lower in TRP+ rats than in 
untreated rats (p<0.05). In SERT- -  rats, 5-HIAA/5-HT was 
higher in TRP- 100 g compared to untreated rats (p<0.001) 
and TRP+ rats (p<0.001). In all genotypes, there was a 
treatment effect in the hippocampus [SERT++: F(2, 20)= 
7.31, p <0.01; SERT+ - : F(2, 21)=4.10, p <0.05; SERT- - : F  
(2, 21)=15.12, p <0.001]. Post hoc testing showed that in 
SERT+/+ rats, 5-HIAA/5-HT was lower in the TRP- 100 g 
group compared to the untreated group (p<0.01). In SERT-/- 
rats, 5-HIAA/5-HT was higher in the TRP- 100 g treated
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rats compared to untreated rats (p<0.01) and TRP+ treated 
rats (p<0.001). In SERT+- rats, no differences in 5-HIAA/5- 
HT were found.
Object recognition task
In order to test whether animals with lower SERT function 
are more vulnerable to the effects of ATD, we tested 
SERT+ +, SERT+- and SERT- -  rats on object recognition 
memory. Exploration times of untreated rats and rats treated 
with TRP+, TRP- 100 g, and TRP- 40 g treated were 
compared (data not shown). There were no Genotype x 
Treatment interaction effects on exploration time in trial 1 
or in trial 2. There was no effect of Genotype or Treatment 
on exploration time in trial 1. In trial 2, there was an effect 
of Genotype [F(2, 136)=3.27, p <0.05] and Treatment [F(3, 
136)=3.98, p <0.01] on exploration time. Post hoc testing 
showed that in trial 2, exploration time was lower in the 
TRP- 100 g and TRP+ condition compared to the TRP- 
40 g condition (p<0.05). As mentioned before, d2 values of 
the untreated rats and the rats treated with TRP+, TRP- 
100 g, and TRP- 40 g of the present study were compared 
with d2 values of a virtual control group with no object 
recognition (see §ik et al. 2003). The effects of Genotype 
and Treatment on discrimination index d2 in the object 
recognition task are shown in Fig. 3.
There was no Genotype x Treatment interaction effect [F 
(8, 138) = 1.28, ns] and no effect of Genotype on discrim­
ination index d2 [F(2, 138)=2.31, ns]. A treatment effect 
was found on the discrimination index d2 [F(4, 146)= 
21.65, p <0.001]; post hoc analysis showed that the 
untreated d2 and the d2 in the TRP+ and TRP- 40 g 
condition differed from the virtual control group with no 
object recognition. Only in the TRP- conditions that rats
were unable to discriminate between the new and familiar 
object after a 1-hour interval. To evaluate whether SERT-/- 
rats were more vulnerable to ATD treatment than SERT+- 
or SERT+ + rats, treatment effects were analyzed within 
each genotype group. There was a treatment effect on d2 in 
all genotypes [SERT+/+ F(4, 50)=17.61, p <0.001; SERT+- 
F(4, 43)=6.00, p <0.01; SERT- -  F(4, 45)=4.92, p <0.01]. 
In the SERT+ +, untreated rats and rats treated with TRP+ 
and TRP- 40 g were different from the virtual controls but 
TRP- 100 g was not. In the SERT+ - , only untreated rats 
and TRP+ treated rats were different from the virtual 
controls but rats treated with TRP- 100 g and TRP- 40 g 
were not. In the SERT-/- rats, only the untreated rats were 
different from the virtual controls whereas rats treated with 
TRP+, TRP- 100 g, and TRP- 40 g were not.
Discussion
In the present study, the effects of standard-dose (TRP- 
100 g) and low-dose (TRP- 40 g) ATD were examined in 
SERT+/+, SERT+/-, and SERT-/- rats in the object recog­
nition task. The biochemical data showed plasma TRP 
depletion of 65% in SERT+/+, 61% in SERT+/ , and 55% in 
SERT-/- rats 4 h after standard-dose TRP-. This decrease 
in plasma TRP levels is in agreement with other ATD 
studies (Jans et al. 2007a; Lieben et al. 2004b). SERT-/- 
rats showed stronger depletion of 5-HT in the frontal cortex 
(63%) than SERT+/+ and SERT+/- (both 19%) rats. Similar 
results were found in the hippocampus, where SERT- -  rats 
also showed a stronger depletion (70%) compared to 
SERT+/ rats (18%) and SERT+/+ rats (13%). Rats treated 
with standard-dose TRP- showed lower 5-HT levels in 
both brain structures compared to TRP+ treated rats and
Fig. 3 Treatment effects in 
SERT+/+, SERT+- , and SERT-/- 
on discrimination index d2. 
Treatment effect *p<0.05 differ­
ence from virtual control group 
with no object recognition 0.6
<U■c£ 
c o'■¡3
J  0.2
0.4
0.0
-0.2
□ Untreated ■ TRP+ □ TRP-40 g □ TRP-100 g 
* * 
i
SERT+/+ SERT+/- SERT-/-
Springer
Psychopharmacology (2008) 200:243-254 251
untreated rats. These effects were most pronounced in 
SERT-/- rats, as only these rats showed significantly lower 
5-HT in the standard-dose TRP- condition than in the 
untreated condition. In both the frontal cortex and hippo­
campus, standard-dose ATD decreased 5-HIAA to a similar 
extent in all genotypes. In SERT+ + and SERT+/ rats, 5- 
HIAA/5-HT turnover was a bit lower in rats treated with 
TRP+ and standard-dose TRP- compared with the untreat­
ed condition, but in SERT- -  rats, this turnover ratio was 
much higher in the standard-dose TRP- group than in the 
TRP+ group and the untreated group. In previous studies, 
SERT- -  animals exhibited an increased 5-HT turnover at 
basal levels in the cortex and caudate putamen, but not in 
the amygdala medial prefrontal cortex, and orbitofrontal 
cortex (Homberg et al. 2007a, b). In line with this, 
untreated SERT-/- animals in this study did not have 
increased 5-HIAA/5-HT turnover in the frontal cortex. 
Although the central effects of ATD were stronger in 
SERT- -  rats, plasma TRP and TRP/ELNAA levels 
decreased to a similar extent in all genotypes. Thus, 
different effects seen in SERT+ +, SERT+ - , and SERT- - 
rats after ATD were found only in the brain and not in the 
periphery. Previous ATD studies reported a similar disso­
ciation between peripheral and central effects (Jans et al 
2007a; Jans et al. unpublished data). Although the reason 
for this difference is not known, it is interesting to note that 
5-HT synthesis in brain and peripheral tissues functions 
differently. For example, tryptophan hydroxylase (TPH), 
the rate-limiting enzyme to form 5-hydroxytryptophan (5- 
HTP) from tryptophan, is controlled by a different isoform 
in the brain than in the periphery (for review, see Walther 
and Bader 2003). This difference in 5-HT synthesis might 
play a role in the different effects seen after ATD in brain 
and periphery.
The standard ATD dose (TRP- 100 g) is known to 
impair object recognition in Wistar rats (Jans et al. 2007a; 
Lieben et al. 2004b) and was thus expected to impair object 
recognition in all genotypes. The re-uptake mechanism in 
SERT+/+ rats is fully functional, whereas this mechanism is 
partly functional in SERT+ rats and not functional in 
SERT-/- rats. Therefore, SERT+- and SERT-/- rats rely 
more heavily on 5-HT synthesis than SERT++ rats. 
Consequently, it was hypothesized that differences in object 
recognition between the genotypes would occur only after 
the low-dose ATD treatment. It was found that all 
genotypes showed impaired object recognition after stan­
dard-dose ATD. The relatively mild depletion of the TRP- 
40 g treatment impaired object recognition in SERT+ -  and 
especially in SERT / rats but not in SERT+ + rats, 
suggesting that SERT / and SERT+/ rats are more 
sensitive to the memory-impairing effects of low-dose 
ATD. In SERT+/+ rats, the d2 in the TRP- 40 g condition 
was lower than in the untreated condition but still different
from the virtual control group with impaired object 
recognition. The stronger effects of the TRP- 40 g 
treatment in SERT-/- rats may be related to the stronger 
effects of TRP- treatment on central 5-HT levels. The same 
dose of TRP- 100 g had a stronger effect on central 5-HT 
levels in SERT / rats compared to SERT+/ and SERT+ + 
rats. Notably, SERT / rats showed impaired object 
recognition after TRP+ treatment as well, although their 
untreated d2 indicated normal object recognition when 
untreated. This may be related to stress associated with the 
ATD procedure, such as the repeated oral injections. 
Chronic stress is known to impair object memory (Beck 
and Luine 1999), and there is some evidence to suggest that 
diminished SERT function is associated with increased 
stress responsivity in humans (for review, see Canli and 
Lesch 2007) and mice (Wellman et al. 2007). In this way, 
the injection stress may have resulted in mildly impaired 
object recognition memory in TRP+ treated SERT- -  rats.
Several 5-HT receptors are known to be involved in 
memory (for review, see Buhot 1997; Perez-Garcia and 
Meneses 2008). ATD can modify 5-HT receptors, for 
example, ATD in rats reduced 5-HT1A binding in the 
dorsal raphe but not in the cortex and hippocampus (Cahir 
et al. 2007). This decrease in autoreceptor binding may 
represent a compensatory intrinsic homeostatic response, 
attempting to counteract ATD-induced decreases in central 
5-HT (Cahir et al. 2007). It is interesting to note that in 
SERT-/- rats, the 5-HT1A receptors are less sensitive due 
to the nine-fold increased extracellular 5-HT levels 
(Olivier et al. unpublished data). The stronger ATD effects 
on memory in SERT rats might be a result of 
adaptations in 5-HT receptors.
ATD has been reported to impair cognitive performance 
in humans (Park et al. 1994; Riedel et al. 1999, 2002; 
Sambeth et al. 2007; Schmitt et al. 2000), and impaired 
object recognition has been found in Wistar rats (Lieben et 
al. 2004a, b; Jans et al. 2007a). The effects of low-dose 
ATD on memory in groups that differ in serotonergic 
functioning have not been studied extensively. Booij et al. 
(2005) found that ATD had a dose-dependent effect on 
selective attention (Stroop color-word interference) in 
remitted depressed patients, but no other cognitive effects 
of low-dose ATD were observed. The magnitude of the 
reduction of plasma tryptophan concentrations following 
ATD depends on the amount and composition of the amino 
acid mixture (Young et al. 1989). In human studies, it has 
been suggested that a threshold exists that needs to be 
exceeded before any behavioral effects occurs since studies 
in which the plasma tryptophan reduction was lower than 
70% generally do not find any symptomatic effects (Van 
Der Does 2001). A similar threshold may also exist in the 
rat, although the level of the threshold is likely to be lower 
as rat studies in general show lower plasma TRP depletion
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than human studies. In the present study, SERT- - , and to a 
smaller extent SERT+ -  rats, showed impairment in recogni­
tion memory after low-dose ATD. Thus, it may be possible 
that in SERT- - , and to a smaller extent in SERT+ -  rats, the 
threshold is lower than in SERT+ + rats, and less depletion of 
TRP is required to cause impaired memory.
The results of this study indicate higher serotonergic 
vulnerability in SERT- -  and to a lesser extent SERT+ -  rats 
than in SERT++ rats as low-dose ATD only affected 
memory in subjects that already have a disturbed 5-HT 
system. Serotonergic vulnerability means that minor 
changes in serotonergic functioning do not cause symptoms 
but make the system more vulnerable so that additional 
challenges of the serotonergic system may result in the 
occurrence of psychiatric symptoms (Jans et al. 2007b). 
Thus, serotonergic vulnerability can be demonstrated by 
challenging the 5-HT system, as is done with ATD; only 
vulnerable subjects will react to such manipulations with 
changes in behavior. Challenging the 5-HT system in 
vulnerable subjects can have stronger effects on the 
memory function of these subjects. ATD in SERT-/- rats 
may therefore be a good tool to investigate serotonergic 
vulnerability.
Some possible limitations of this study have to be 
mentioned. First, plasma amino acid concentrations and 
brain 5-HT and 5-HIAA levels after the low-dose TRP- 
40 g treatment could not be determined in this study due to 
the limited number of rats that were available for this study. 
Previous standard-dose ATD studies have shown a robust 
reduction in plasma TRP (about 70%) and central tissue 5- 
HT (about 40-45%) concentrations in male Wistar rats 
(Lieben et al. 2004a). Lowering the concentration of 
Solugel protein in the TRP- mixture had dose-dependent 
effects on the plasma TRP/ELNAA ratio in previous 
research, and there was a positive correlation between the 
plasma TRP/ELNAA ratio and performance in the object 
recognition task (Lieben et al. unpublished data). We can 
therefore assume that the low-dose TRP- 40 g treatment 
resulted in milder TRP and 5-HT depletion. Further 
research may elucidate the exact level of peripheral and 
central depletion that is required to impair object recogni­
tion memory in SERT+ +, SERT+/ , and SERT / rats. 
Secondly, the TRP+ treatment resulted in increased levels 
of plasma TRP and brain 5-HT, suggesting an active 
control. Essentially, this means that we compared TRP 
depletion and mild TRP suppletion in all rats. This may 
have affected behavior in the TRP+ condition. Although 
these treatment effects in the TRP+ condition occurred to a 
similar degree in all genotypes, it cannot be excluded that 
the mild TRP suppletion had different effects in SERT+ +, 
SERT+/ , and SERT / rats. A third concern could be that 
the same group of rats were repeatedly subjected to ATD 
treatment (for the measurement of plasma levels, for the ORT,
and eventually for the measurement of brain levels), although 
the treatment condition varied between tests. Previous ATD 
studies have shown that repeated treatment did not alter the 
effect of the treatment on the plasma TRP/ELNAA ratio and 
that plasma levels returned to baseline levels on the treatment 
day (Jans et al. unpublished data). We therefore assume that 
the treatment has had comparable biochemical effects 
throughout the study.
The aim of the present study was to investigate whether 
male SERT+ +, SERT+ - , and SERT- -  serotonin transporter 
rats differed in their response to ATD with respect to object 
memory. Without treatment, all rats showed normal object 
recognition memory. After a standard 100-g dose of ATD, 
object recognition memory was impaired in all genotypes. 
However, in the low-dose ATD condition, SERT+ and 
SERT-/- rats showed increased responsiveness to the 
treatment than SERT+ + rats by showing impaired object 
recognition after this relatively mild ATD treatment. 
Therefore, ATD in SERT-/- rats might be a valuable animal 
model to investigate serotonergic vulnerability. It can be 
concluded that there is a SERT gene-dosage effect with 
respect to the behavioral response to TRP depletion in the 
object recognition task. Because ATD decreased 5-HT 
levels in brain structures that play a crucial role in memory, 
such as the hippocampus and the frontal cortex, the 
outcome of the present study underlines the relevance of 
the serotonergic system in memory.
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